Authors
John Michael O’Brien, PharmD, MPH, is president and CEO of the National Pharmaceutical Council.
ORCID ID: 0009-0003-1578-2500
Medical director, Asklepios Tumour Biology Centre
Advertisement
Advertisement
Trending on AJMC
1
FDA Panel Backs 6 Peptides for Compounding
2
Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care
3
Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%
4
Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access
5

